Defibrinating agents: effects on blood rheology, blood flow and vascular diseases in controlled studies.
D000721:Ancrod / Q000627:therapeutic use*; D000818:Animals; D012103:Batroxobin / Q000627:therapeutic use*; D001809:Blood Viscosity / Q000187:drug effects; D002986:Clinical Trials as Topic; D006801:Humans; D010447:Peptide Hydrolases / Q000627:therapeutic use*; D014652:Vascular Diseases / Q000188:drug therapy*
D010447:Peptide Hydrolases; D000721:Ancrod; D012103:Batroxobin